Medical News Today: Chronic migraine severity reduced with investigational drug

In a phase IIb study, an investigational drug called eptinezumab led to a significant reduction in the severity of chronic migraine.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Headache / Migraine Source Type: news
More News: Headache | Health | Migraine | Study